Caitlin Peaslee1, Cristina Esteva-Font1, Tao Su1, Antonio Munoz-Howell2, Caroline C Duwaerts3,4, Zhe Liu5,6,7, Sneha Rao5,6,7, Ke Liu2, Marisa Medina2,4, Julie B Sneddon5,6,7,8, Jacquelyn J Maher3,4,7, Aras N Mattis1,4. 1. Department of Pathology, University of California San Francisco, San Francisco, CA. 2. Children's Hospital Oakland Research Institute, University of California San Francisco, San Francisco, CA. 3. Department of Medicine, University of California San Francisco, San Francisco, CA. 4. Liver Center, University of California San Francisco, San Francisco, CA. 5. Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA. 6. Diabetes Center, University of California San Francisco, San Francisco, CA. 7. Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA. 8. Department of Anatomy, University of California San Francisco, San Francisco, CA.
Abstract
BACKGROUND AND AIMS: Induced pluripotent stem cells (iPSCs) provide an important tool for the generation of patient-derived cells, including hepatocyte-like cells, by developmental cues through an endoderm intermediate. However, most iPSC lines fail to differentiate into endoderm, with induction resulting in apoptosis. APPROACH AND RESULTS: To address this issue, we built upon published methods to develop an improved protocol. We discovered that doxycycline dramatically enhances the efficiency of iPSCs to endoderm differentiation by inhibiting apoptosis and promoting proliferation through the protein kinase B pathway. We tested this protocol in >70 iPSC lines, 90% of which consistently formed complete sheets of endoderm. Endoderm generated by our method achieves similar transcriptomic profiles, expression of endoderm protein markers, and the ability to be further differentiated to downstream lineages. CONCLUSIONS: Furthermore, this method achieves a 4-fold increase in endoderm cell number and will accelerate studies of human diseases in vitro and facilitate the expansion of iPSC-derived cells for transplantation studies.
BACKGROUND AND AIMS: Induced pluripotent stem cells (iPSCs) provide an important tool for the generation of patient-derived cells, including hepatocyte-like cells, by developmental cues through an endoderm intermediate. However, most iPSC lines fail to differentiate into endoderm, with induction resulting in apoptosis. APPROACH AND RESULTS: To address this issue, we built upon published methods to develop an improved protocol. We discovered that doxycycline dramatically enhances the efficiency of iPSCs to endoderm differentiation by inhibiting apoptosis and promoting proliferation through the protein kinase B pathway. We tested this protocol in >70 iPSC lines, 90% of which consistently formed complete sheets of endoderm. Endoderm generated by our method achieves similar transcriptomic profiles, expression of endoderm protein markers, and the ability to be further differentiated to downstream lineages. CONCLUSIONS: Furthermore, this method achieves a 4-fold increase in endoderm cell number and will accelerate studies of human diseases in vitro and facilitate the expansion of iPSC-derived cells for transplantation studies.
Authors: Tenneille E Ludwig; Veit Bergendahl; Mark E Levenstein; Junying Yu; Mitchell D Probasco; James A Thomson Journal: Nat Methods Date: 2006-08 Impact factor: 28.547
Authors: Xiaocui Ma; Yuyou Duan; Benjamin Tschudy-Seney; Garrett Roll; Iman Saramipoor Behbahan; Tijess P Ahuja; Vladimir Tolstikov; Charles Wang; Jeannine McGee; Shiva Khoobyari; Jan A Nolta; Holger Willenbring; Mark A Zern Journal: Stem Cells Transl Med Date: 2013-05-16 Impact factor: 6.940
Authors: Jason S L Yu; Thamil Selvee Ramasamy; Nick Murphy; Marie K Holt; Rafal Czapiewski; Shi-Khai Wei; Wei Cui Journal: Nat Commun Date: 2015-05-22 Impact factor: 14.919
Authors: Thomas Frogne; Anne-Vibeke Laenkholm; Maria B Lyng; Katrine Lütken Henriksen; Anne E Lykkesfeldt Journal: Breast Cancer Res Date: 2009-02-24 Impact factor: 6.466